HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population

References

• Gopal S, Patel MR, Yanik EL, et al. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst 2013;105:1221–1229.
   PubMed Web of Science ®Google Scholar
• Achenbach CJ, Cole SR, Kitahata MM, et al. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS 2011;25:691–700.
   PubMed Web of Science ®Google Scholar
• Chao C, Xu L, Abrams D, et al. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS 2010;24:1765–1770.
   PubMed Web of Science ®Google Scholar
• Gibson TM, Morton LM, Shiels MS, et al. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 2014;28:2313–2318.
   PubMedGoogle Scholar
• Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645–1654.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103:753–762.
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59–67.
   PubMed Web of Science ®Google Scholar
• Guiguet M, Boue F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009;10:1152–1159.
   PubMed Web of Science ®Google Scholar
• Bruyand M, Thiebaut R, Lawson-Ayayi S, et al. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis 2009;49:1109–1116.
   PubMed Web of Science ®Google Scholar
• Zoufaly A, Stellbrink HJ, Heiden MA, et al. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis 2009;200:79–87.
   PubMed Web of Science ®Google Scholar
• Chadburn A, Chiu A, Lee JY, et al. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol 2009;27:5039–5048.
   PubMed Web of Science ®Google Scholar
• Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009;523–531.
   Google Scholar
• Gerard L, Meignin V, Galicier L, et al. Characteristics of non-Hodgkin lymphoma arising in HIV-infected patients with suppressed HIV replication. AIDS 2009;23:2301–2308.
   PubMed Web of Science ®Google Scholar
• Gopal S, Martin KE, Richards KL, et al. Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010. AIDS Res Hum Retroviruses 2012;28:798–805.
   PubMed Web of Science ®Google Scholar
• Xicoy B, Ribera JM, Mate JL, et al. Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection. Leuk Lymphoma 2010;51:2063–2069.
   PubMed Web of Science ®Google Scholar
• Coutinho R, Pria AD, Gandhi S, et al. HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era. AIDS 2014;28:689–697.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 2013;164:536–545.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Surveillance, Epidemiology, and End Results Program: SEER Stat Fact Sheets: Non-Hodgkin Lymphoma. 2013. Available from: http://seer.cancer.gov/statfacts/html/nhl.html. Accessed April 11, 2015.
   Google Scholar
• Rudek MA, Flexner C, Ambinder RF. Use of antineoplastic agents in patients with cancer who have HIV/AIDS. Lancet Oncol 2011;12:905–912.
   PubMed Web of Science ®Google Scholar
• Silverton A, Gunthel C, Adamski M, et al. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era. AIDS Res Hum Retroviruses 2014;30:665–669.
   PubMed Web of Science ®Google Scholar
• Long JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 2008;22:489–496.
   PubMed Web of Science ®Google Scholar
• Riedel DJ, Mwangi EI, Fantry LE, et al. High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS 2013;27:1109–1117.
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Tiemann M, Schrader C, et al. AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping. Blood 2005;106:1762–1769.
   PubMed Web of Science ®Google Scholar
• Morton LM, Kim CJ, Weiss LM, et al. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. Leuk Lymphoma 2014;55:551–557.
   PubMed Web of Science ®Google Scholar
• Thompson LD, Fisher SI, Chu WS, et al. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol 2004;121:727–738.
   PubMed Web of Science ®Google Scholar
• Pather S, Mohamed Z, McLeod H, et al. Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping. Pathol Oncol Res 2013;19:695–705.
   PubMed Web of Science ®Google Scholar
• Simard EP, Pfeiffer RM, Engels EA. Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS 2012;26:1311–1318.
   PubMed Web of Science ®Google Scholar